Journal of Medicinal Chemistry p. 2318 - 2325 (1989)
Update date:2022-08-05
Topics:
DeVries, Vern G.
Bloom, Jonathan D.
Dutia, Minu D.
Katocs, Andrew S.
Largis, Elwood E.
The discovery that a series of N,N-dialkyl-N'-arylureas were inhibitors of the ACAT enzyme has led to a structure-activity study involving the systematic modification of three sites of the urea backbone.This study culminated in the selection of N'-(2,4-dimethylphenyl)-N-benzyl-N-n-butylurea (115) for more extensive biological evaluation.ACAT inhibitors are seen as potentially beneficial agents against hypercholesterolemia and atherosclerosis.
View MoreAnhui Redstar Pharmaceutical Corp., Ltd
Contact:+86-563-5120837
Address:Jingxian Industrial Development Zone, Anhui , China
Taizhou Elitechemie MediPharma Technology Co.,Ltd.
Contact:+86-523-86810021
Address:Building G14,NO.1 Avenue,China Medical City, Taizhou, Jiangsu,China
Sinoway International (Jiangsu) Co., Ltd.
Contact:+86-25-86630167
Address:17 Beijing Road (West), Nanjing, China
Suzhou Tianma Specialty Chemicals Co.,Ltd
Contact:+86-512-68090577
Address:#199, Huayuan Rd, Mudu, Suzhou, Jiangsu, CHINA
Contact:0512-63006287
Address:no.88.YISHENG Road,etdz-WUJIANG,SUZHOU,CHINA
Doi:10.1021/jo052569u
(2006)Doi:10.1021/ic052091c
(2006)Doi:10.1016/j.bmc.2005.11.043
(2006)Doi:10.1016/S0022-328X(00)99299-4
(1983)Doi:10.1021/ic052158w
(2006)Doi:10.1021/jo0711539
(2007)
